Predictors of response to anifrolumab in cutaneous lupus erythematosus: a prospective cohort study of 57 Patients - Supplementary Material

Predictors of response to anifrolumab in cutaneous lupus erythematosus: a prospective cohort study of 57 Patients - Supplementary Material Table S1. Clinical and biological characteristics of patients at anifrolumab initiation Table S2. Factors associated with CLASI-70 response at 6 months after anifrolumab initiation Figure S3.Retention rate according to presence of cutaneous involvement Table S4. Treatment discontinuation rates and adverse events Table S5. Individual motives for treatment discontinuation Supplementary materials S6. Materials and methods for assessment of interferon gene signature皮肤红斑狼疮患者对阿尼鲁单抗应答的预测因素：一项纳入57例患者的前瞻性队列研究——补充材料 表S1 阿尼鲁单抗启动治疗时患者的临床及生物学特征 表S2 阿尼鲁单抗启动治疗后6个月时与CLASI-70应答相关的因素 图S3 按皮肤受累情况划分的患者留存率 表S4 治疗停药率与不良事件 表S5 治疗停药的个体动因 补充材料S6 干扰素基因特征评估的材料与方法